# Alzamend Neuro, Inc.: filings

ALZN · Nasdaq · CIK 1677077 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/alzn.md) · [Financials](/companies/alzn/financials.md) · [Filings](/companies/alzn/filings.md) · [Insiders](/companies/alzn/insiders.md)

## Reports and events: 121 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 143, 8-K 69, CORRESP 19, 10-Q 16, UPLOAD 12, 3 11, 1-U 9, 5 8, S-1/A 7, 10-K 6, DEF 14A 6, DEFA14A 6, PRE 14A 6, SCHEDULE 13D/A 6, 1-SA 5, 424B5 5, SC 13D/A 5, 1-K 4, 4/A 4, EFFECT 4, 1-A/A 3, D 3, S-1 3, 1-A 2, 424B3 2, 8-K/A 2, DOS/A 2, DOSLTR 2, DRSLTR 2, FWP 2, S-3 2, 1-A-W 1, 1-SA/A 1, 1-U/A 1, 424B4 1, 8-A12B 1, CERT 1, DOS 1, DRS 1, DRS/A 1, NT 10-K 1, NT 10-Q 1, QUALIF 1, RW 1, S-8 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 10:30 ET | [8-K](/filings/0001214659-26-012132.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-26-012132 |
| 2026-09-10 | 20:30 ET | [10-Q](/filings/0001214659-26-011572.md) | Quarterly report, period 2026-07-31 | 0001214659-26-011572 |
| 2026-08-21 | 20:30 ET | [S-1](/filings/0001214659-26-010726.md) | Registration statement | 0001214659-26-010726 |
| 2026-08-03 | 20:30 ET | [8-K](/filings/0001214659-26-009469.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001214659-26-009469 |
| 2026-07-22 | 20:30 ET | [10-K](/filings/0001214659-26-008832.md) | Annual report, period 2026-04-30 | 0001214659-26-008832 |
| 2026-07-21 | 20:30 ET | [8-K](/filings/0001214659-26-008772.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001214659-26-008772 |
| 2026-04-17 | 20:30 ET | [8-K](/filings/0001214659-26-004806.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001214659-26-004806 |
| 2026-03-20 | 20:30 ET | [8-K](/filings/0001214659-26-003620.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001214659-26-003620 |
| 2026-03-11 | 20:30 ET | [10-Q](/filings/0001214659-26-003166.md) | Quarterly report, period 2026-01-31 | 0001214659-26-003166 |
| 2026-03-06 | 21:30 ET | [8-K](/filings/0001214659-26-002932.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001214659-26-002932 |
| 2026-02-26 | 22:12 ET | [DEF 14A](/filings/0001214659-26-002583.md) | Proxy statement, period 2026-04-17 | 0001214659-26-002583 |
| 2025-12-09 | 21:30 ET | [10-Q](/filings/0001214659-25-017793.md) | Quarterly report, period 2025-10-31 | 0001214659-25-017793 |
| 2025-11-18 | 21:30 ET | [8-K](/filings/0001214659-25-016885.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001214659-25-016885 |
| 2025-10-14 | 20:51 ET | [8-K](/filings/0001214659-25-014950.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001214659-25-014950 |
| 2025-10-09 | 20:30 ET | [8-K](/filings/0001214659-25-014818.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001214659-25-014818 |
| 2025-10-07 | 01:53 ET | [SCHEDULE 13D/A](/filings/0001214659-25-014750.md) | Ownership report, active investor, amended | 0001214659-25-014750 |
| 2025-10-03 | 01:37 ET | [SCHEDULE 13D/A](/filings/0001214659-25-014630.md) | Ownership report, active investor, amended | 0001214659-25-014630 |
| 2025-09-30 | 00:51 ET | [SCHEDULE 13D/A](/filings/0001214659-25-014424.md) | Ownership report, active investor, amended | 0001214659-25-014424 |
| 2025-09-25 | 01:37 ET | [SCHEDULE 13D/A](/filings/0001214659-25-014211.md) | Ownership report, active investor, amended | 0001214659-25-014211 |
| 2025-09-25 | 20:30 ET | [8-K](/filings/0001214659-25-014200.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001214659-25-014200 |
| 2025-09-23 | 20:30 ET | [SCHEDULE 13D/A](/filings/0001214659-25-014057.md) | Ownership report, active investor, amended | 0001214659-25-014057 |
| 2025-09-10 | 20:30 ET | [10-Q](/filings/0001214659-25-013609.md) | Quarterly report, period 2025-07-31 | 0001214659-25-013609 |
| 2025-08-01 | 00:52 ET | [SCHEDULE 13D/A](/filings/0001214659-25-011394.md) | Ownership report, active investor, amended | 0001214659-25-011394 |
| 2025-08-01 | 20:30 ET | [8-K](/filings/0001214659-25-011357.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001214659-25-011357 |
| 2025-07-23 | 20:30 ET | [8-K](/filings/0001214659-25-010830.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001214659-25-010830 |
| 2025-07-22 | 20:30 ET | [10-K](/filings/0001214659-25-010763.md) | Annual report, period 2025-04-30 | 0001214659-25-010763 |
| 2025-07-09 | 20:30 ET | [8-K](/filings/0001214659-25-010209.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001214659-25-010209 |
| 2025-05-08 | 20:30 ET | [8-K](/filings/0001214659-25-007204.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-25-007204 |
| 2025-04-25 | 20:30 ET | [8-K](/filings/0001214659-25-006405.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001214659-25-006405 |
| 2025-03-27 | 20:30 ET | [S-1/A](/filings/0001214659-25-004902.md) | Registration statement, amended | 0001214659-25-004902 |
| 2025-03-13 | 21:00 ET | [DEF 14A](/filings/0001214659-25-004335.md) | Proxy statement, period 2025-04-25 | 0001214659-25-004335 |
| 2025-03-10 | 20:30 ET | [10-Q](/filings/0001214659-25-004123.md) | Quarterly report, period 2025-01-31 | 0001214659-25-004123 |
| 2025-03-03 | 21:30 ET | [8-K](/filings/0001214659-25-003727.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001214659-25-003727 |
| 2025-02-28 | 21:30 ET | [8-K](/filings/0001214659-25-003658.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001214659-25-003658 |
| 2024-12-12 | 21:30 ET | [8-K](/filings/0001214659-24-020439.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001214659-24-020439 |
| 2024-12-11 | 21:30 ET | [10-Q](/filings/0001214659-24-020264.md) | Quarterly report, period 2024-10-31 | 0001214659-24-020264 |
| 2024-10-15 | 20:30 ET | [8-K](/filings/0001214659-24-017549.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-017549 |
| 2024-10-03 | 20:30 ET | [8-K](/filings/0001214659-24-017141.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001214659-24-017141 |
| 2024-09-11 | 20:30 ET | [10-Q](/filings/0001214659-24-016346.md) | Quarterly report, period 2024-07-31 | 0001214659-24-016346 |
| 2024-07-31 | 20:30 ET | [8-K](/filings/0001214659-24-013382.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-013382 |
| 2024-07-30 | 20:30 ET | [10-K](/filings/0001214659-24-013191.md) | Annual report, period 2024-04-30 | 0001214659-24-013191 |
| 2024-07-12 | 20:30 ET | [8-K](/filings/0001214659-24-012340.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-012340 |
| 2024-07-08 | 20:30 ET | [8-K](/filings/0001214659-24-012079.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001214659-24-012079 |
| 2024-07-03 | 20:31 ET | [S-1/A](/filings/0001214659-24-011977.md) | Registration statement, amended | 0001214659-24-011977 |
| 2024-06-26 | 20:46 ET | [S-1/A](/filings/0001214659-24-011445.md) | Registration statement, amended | 0001214659-24-011445 |
| 2024-06-03 | 20:30 ET | [S-1](/filings/0001214659-24-010447.md) | Registration statement | 0001214659-24-010447 |
| 2024-05-31 | 20:59 ET | [DEF 14A](/filings/0001214659-24-010336.md) | Proxy statement, period 2024-07-08 | 0001214659-24-010336 |
| 2024-05-22 | 20:30 ET | [8-K](/filings/0001214659-24-009785.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-009785 |
| 2024-05-15 | 20:30 ET | [8-K](/filings/0001214659-24-009345.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001214659-24-009345 |
| 2024-05-13 | 20:30 ET | [8-K](/filings/0001214659-24-008914.md) | 9.01 Financial statements and exhibits | 0001214659-24-008914 |

Page 1 of 3. [Older](/companies/alzn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.